Data / Form D filings / Kereos, Inc
Kereos, Inc: Form D filings
Kereos, Inc, a pharmaceuticals company in St. Louis, MO, filed 3 Form D notices with the SEC between 2009 and 2012. The latest, on January 12, 2012, reports $1.1 million sold of a $1.1 million offering to 9 investors.
Find out what Kereos, Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4041 FOREST PARK AVE, St. Louis, MO, 63108
- Phone
- (314) 633-1879
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1329246
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 12, 2012 | New notice | $1,127,730 | $1,127,730 | $0 | 9 | Sep 23, 2011 | sec.gov |
| May 6, 2010 | New notice | $6,217,618 | $5,675,098 | $542,520 | 13 | Apr 23, 2010 | sec.gov |
| Jun 26, 2009 | New notice | $887,426 | $887,126 | $300 | 13 | Jun 15, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael D. Loberg, Ph. D. | Director | |
| Fred A. Schwarzer, J.D. | Director | |
| Gregory R. Johnson, Ph. D. | Director | |
| Samuel A. Wickline, M.D. | Director | |
| Gary A. Stevenson | Director | |
| John D. Rice, Ph. D. | Director | |
| Phillip M. Buckler | Executive Officer |
Other pharmaceuticals companies in Missouri that filed recently
- Immunophotonics, Inc. $10.1 million · Sep 4, 2026
Every Form D from the week of Jan 9, 2012 · All recent filings in Missouri · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Kereos, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.